# The Assessment of the Use of Anti-Adhesion Agents to Prevent Pelvic Postoperative Adhesions

> **NCT04063085** · NA · COMPLETED · sponsor: **SciVision Biotech Inc.** · enrollment: 188 (actual)

## Conditions studied

- Tissue Adhesion
- Gynecologic Surgery

## Interventions

- **DEVICE:** PROTAHERE Absorbable Adhesion Barrier
- **DEVICE:** Hyalobarrier Gel
- **OTHER:** No treatment
- **DEVICE:** Seprafilm Adhesion Barrier
- **DEVICE:** Gynecare Interceed (TC7) Absorbable Adhesion Barrier

## Key facts

- **NCT ID:** NCT04063085
- **Lead sponsor:** SciVision Biotech Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-25
- **Primary completion:** 2022-01-05
- **Final completion:** 2023-10-12
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2024-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04063085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04063085, "The Assessment of the Use of Anti-Adhesion Agents to Prevent Pelvic Postoperative Adhesions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04063085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*